Our Comprehensive Diagnostic Offering

Learn About Castle’s Comprehensive Diagnostic Offering

Our suite of highly accurate tests for melanocytic lesions of uncertain potential increases diagnostic confidence and enables better clinical management plans for patients. Learn the essentials from this comprehensive introduction by Matthew Goldberg, MD, Medical Director for Castle Biosciences.

“We’re bringing two gene expression profile tests to the care of patients with difficult-to-diagnose melanocytic neoplasms, to go from uncertainty to certainty.”

– Matthew Goldberg, MD, Medical Director, Castle Biosciences

What's Next?

Overview: Designed to Reduce Diagnostic Uncertainty

A comprehensive testing solution for difficult-to-diagnose melanocytic lesions.

LEARN MORE

Why GEP?

Genetic Expression Profile testing can help reduce diagnostic uncertainty when clinical and histopathologic approaches cannot.

LEARN MORE